Andrew J. Mills insider trades: Medline (MDLN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andrew reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | MDLN | ↑ Buy | 2,586,206 | $29.00 | $75.0M | Indirect | Dec 22, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MDLN insiders
Open-market trades in the last 12 months
About Andrew J. Mills's insider trades
Andrew J. Mills is an insider at Medline (MDLN). Since Dec 18, 2025, Andrew has reported 1 open-market purchase worth $75.0M and no sales on SEC Form 4. In the last 12 months: 1 buy ($75.0M).
Their filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDLN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.